Regeneron Pharmaceuticals stock was among the biggest S&P 500 and Nasdaq decliners Tuesday after the biotech firm reported ...

Tesla (TSLA) is at a crossroads. Once the undisputed leader of the electric vehicle revolution, the company now faces a ...

On April 24 this reporter posted an article titled “How much was Elon Musk’s pledge to step back from DOGE worth? $67 billion ...

BI examined sentiment data, markets chaos, and interviews with small business owners, consumers, and economists. They point ...

Despite missing Q1 2025 expectations and delaying its FY 2025 guidance update, Tesla's stock is up by 20% since the results ...

Despite poor Q1 results, Elon Musk reaffirmed timelines for key projects. See why Tesla (TSLA) stock upgraded to a buy amid ...

Despite the bump that it received last week after Elon Musk’s earnings announcement, Tesla is still facing an uphill battle.

Meta Platforms is set to report first-quarter results after markets close on Wednesday. Analysts have remained bullish on the ...